Cryo Cell International (CCEL) Depreciation & Amortization (CF) (2018 - 2026)
Cryo Cell International (CCEL) posted quarterly Depreciation & Amortization (CF) of $243633.0 for Q2 2026, down 2.6% year-over-year from $250131.0 in Q2 2025, and little changed quarter-over-quarter from $244212.0 in Q1 2026.
Cryo Cell International (CCEL) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $243633.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) fell 2.6% year-over-year to $243633.0; the TTM figure through May 2026 stood at $974946.0 (down 1.89% YoY), while the FY2025 annual figure was $985242.0, up 42.0% from the prior year.
- Depreciation & Amortization (CF) steadied at $243633.0 in Q2 2026 per CCEL's latest filing, from $244212.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $396112.0 in Q1 2022 and bottomed at $86047.0 in Q1 2024.
- Historically, Depreciation & Amortization (CF) has averaged $281415.8 across 5 years, with a median of $249564.0 in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 446.44% — and 2024, when it sank 76.74%.
- Cryo Cell International's Depreciation & Amortization (CF) stood at $369079.0 in 2022, then dropped by 8.99% to $335896.0 in 2023, then declined by 25.87% to $248997.0 in 2024, then slipped by 2.4% to $243011.0 in 2025, then rose by 0.26% to $243633.0 in 2026.
- Business Quant data shows CCEL's Depreciation & Amortization (CF) at $243633.0 in Q2 2026, $244212.0 in Q1 2026, and $243011.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 944.00 Mn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 215.00 Mn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 90.40 Mn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 31.41 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 167.34 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 16.99 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 19.90 Mn |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | 243,633.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 243,633.00 |
| May 31, 2026 | 243,633.00 |
| Feb 28, 2026 | 244,212.00 |
| Feb 28, 2026 | 244,212.00 |
| Nov 30, 2025 | 243,011.00 |
| Nov 30, 2025 | 243,011.00 |
| Aug 31, 2025 | 244,090.00 |
| Aug 31, 2025 | 244,090.00 |
| May 31, 2025 | 250,131.00 |
| May 31, 2025 | 250,131.00 |
| Feb 28, 2025 | 248,010.00 |
| Feb 28, 2025 | 248,010.00 |
| Nov 30, 2024 | 248,997.00 |
| Nov 30, 2024 | 248,997.00 |
| Aug 31, 2024 | 246,586.00 |
| Aug 31, 2024 | 246,586.00 |
| May 31, 2024 | 112,217.00 |
| May 31, 2024 | 112,217.00 |
| Feb 29, 2024 | 86,047.00 |
| Feb 29, 2024 | 86,047.00 |